Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TANC2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | PEX5L | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | RBM3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | YIPF4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | KAT8 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
mRNA | GPC2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
mRNA | C22orf39 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
mRNA | OR2AE1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | UBE2QL1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | FAM134C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |